FDA Inspection 972643 — telaGen, LLC

telaGen, LLC — FEI 3011896967

The FDA completed an inspection of telaGen, LLC on May 11, 2016 in Mobile, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 11, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mobile, AL (United States)

Citations

IDCFRDescription
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1241121 CFR 1271.260(a)Contamination, mix ups, improper release